Concepedia

Author

Keiko Minashi

National Cancer Center Hospital EastORCID

Also Known As

K Minashi, K. Minashi, KEIKO MINASHI, Keiko MINASHI, Keiko Minashi

228

Publications

8.5K

Citations

36

H-Index

69

Concepts

All Affiliations

National Cancer Center Hospital EastChiba Cancer CenterShizuoka Cancer CenterAichi Cancer CenterKyoto University
KM

About

Keiko Minashi is an author at National Cancer Center Hospital East specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

23

37

5.6K

2

Health Sciences

10

11

951

3

Public Health

2

2

358

4

Cell Biology

1

1

13

5

Epidemiology

1

1

345

Keiko Minashi

×

66

Publications

8.2K

Citations

36

H-Index

YearCitations

Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial

Yoon‐Koo Kang, Narikazu Boku, Taroh Satoh,

The Lancet

2017

2.2K

Early Detection of Superficial Squamous Cell Carcinoma in the Head and Neck Region and Esophagus by Narrow Band Imaging: A Multicenter Randomized Controlled Trial

Manabu Muto, Keiko Minashi, Tomonori Yano,

Journal of Clinical Oncology

2010

679

Development and evaluation of FSSG: frequency scale for the symptoms of GERD

Motoyasu Kusano, Yasuyuki Shimoyama, Sayaka Sugimoto,

Journal of Gastroenterology

2004

473

Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial

Toshihiro Kudo, Yasuo Hamamoto, Ken Kato,

The Lancet Oncology

2017

378

Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1

Yuko Kitagawa, Ryu Ishihara, Hitoshi Ishikawa,

Esophagus

2023

345

Phase II Study of Chemoradiotherapy With 5-Fluorouracil and Cisplatin for Stage II–III Esophageal Squamous Cell Carcinoma: JCOG Trial (JCOG 9906)

Ken Kato, Kei Muro, Keiko Minashi,

International Journal of Radiation Oncology*Biology*Physics

2010

342

Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4)

Narikazu Boku, Min‐Hee Ryu, Ken Kato,

Annals of Oncology

2018

317

A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data

Li‐Tzong Chen, Taroh Satoh, Min‐Hee Ryu,

Gastric Cancer

2019

223

Efficacy of Endoscopic Resection and Selective Chemoradiotherapy for Stage I Esophageal Squamous Cell Carcinoma

Keiko Minashi, Keiji Nihei, Junki Mizusawa,

Gastroenterology

2019

200

Esophageal cancer practice guidelines 2022 edited by the Japan Esophageal Society: part 2

Yuko Kitagawa, Ryu Ishihara, Hitoshi Ishikawa,

Esophagus

2023

168

Page 1